TPY Capital

TPY Capital is a venture capital firm based in Tel Aviv, Israel, founded in 2011. The firm focuses on early-stage investments, targeting both pre-revenue and revenue-stage startups, particularly within the technology sector. TPY Capital specializes in areas such as data and analytics, human augmentation, enterprise digitization, cloud infrastructure, and quantum computing. The firm is committed to investing in Israeli companies and typically prefers to take minority positions in its investments. Unlike some venture capital firms, TPY Capital does not engage in sectors like medical devices, biotech, B2B, B2C, or B2B2C. The firm positions itself as an active investor, often leading funding rounds while collaborating with talented entrepreneurs in the region.

Sharon Gal

Venture Partner

Shlomit Harth

Venture Partner

Jacky Tache

Founding Partner

Past deals in Israel

AI21 Labs

Series B in 2022
AI21 Labs, founded in 2017 and based in Tel Aviv-Yafo, Israel, specializes in developing generative artificial intelligence and large language models. The company creates tools designed to enhance the understanding and generation of natural language, effectively transforming how users read and write. Its AI-driven writing companion captures real intelligence, rephrasing text to convey precise meanings while providing summaries that aid in comprehension. These innovations empower users to analyze and visualize complex information more efficiently, facilitating a deeper understanding of abstract knowledge structures. Through the application of deep learning and computer vision algorithms, AI21 Labs aims to significantly improve the efficiency of reading and writing processes.

UNIPaaS Payments Technologies

Seed Round in 2021
UNIPaaS is a payment solution that enables digital platforms and marketplaces to own, manage, and monetize from financial services. Digital marketplaces and B2B platforms can now own their payment experience and control their funds' flow. They are transforming how businesses integrate and handle payments, reducing financial operations costs, and accelerating the implementation of new growth engines powered by payments and financial services. By monetizing these activities and providing these new services to customers in the right context, digital platforms can effectively increase stickiness, and lifetime value, and generate additional revenues. UNIPaaS was founded in 2020 and is based in Israel.

AI21 Labs

Series A in 2020
AI21 Labs, founded in 2017 and based in Tel Aviv-Yafo, Israel, specializes in developing generative artificial intelligence and large language models. The company creates tools designed to enhance the understanding and generation of natural language, effectively transforming how users read and write. Its AI-driven writing companion captures real intelligence, rephrasing text to convey precise meanings while providing summaries that aid in comprehension. These innovations empower users to analyze and visualize complex information more efficiently, facilitating a deeper understanding of abstract knowledge structures. Through the application of deep learning and computer vision algorithms, AI21 Labs aims to significantly improve the efficiency of reading and writing processes.

H2Pro

Seed Round in 2019
H2Pro, Ltd. is a renewable energy company based in Caesarea, Israel, founded in 2019. The company specializes in developing innovative water-splitting technology aimed at producing hydrogen fuel efficiently. Its proprietary method, known as E-TAC (Electrochemical–Thermally-Activated Chemical water splitting), effectively decouples the hydrogen and oxygen evolution reactions, allowing for the generation of hydrogen and oxygen in separate phases. This technology is designed to facilitate the widespread adoption of sustainable hydrogen fuel by providing an efficient, affordable, safe, and environmentally friendly means of hydrogen production.

AI21 Labs

Seed Round in 2019
AI21 Labs, founded in 2017 and based in Tel Aviv-Yafo, Israel, specializes in developing generative artificial intelligence and large language models. The company creates tools designed to enhance the understanding and generation of natural language, effectively transforming how users read and write. Its AI-driven writing companion captures real intelligence, rephrasing text to convey precise meanings while providing summaries that aid in comprehension. These innovations empower users to analyze and visualize complex information more efficiently, facilitating a deeper understanding of abstract knowledge structures. Through the application of deep learning and computer vision algorithms, AI21 Labs aims to significantly improve the efficiency of reading and writing processes.

Clicktale

Series B in 2013
Clicktale Ltd. is a provider of cloud-based software solutions focused on digital customer experience management. Founded in 2006 and headquartered in Ramat Gan, Israel, with additional offices in the United States and the United Kingdom, Clicktale offers a range of services designed to help businesses understand and enhance their online interactions with customers. Its offerings include Clicktale Core, which tracks and analyzes digital customer experiences, and the Clicktale Experience Cloud, a platform that addresses critical customer insights to improve business outcomes. Key features such as Session Playback and Data-Rich Heatmaps allow businesses to visualize user behavior, revealing insights into how visitors engage with websites. By leveraging advanced analytics, machine learning, and psychological research, Clicktale enables companies to interpret customer intent and optimize conversion rates across various sectors, including e-commerce, finance, telecommunications, and media. Its global clientele includes prominent brands such as Walmart and Microsoft, reflecting its impact on enhancing digital experiences and driving business results.

Enzymotec

Series B in 2012
Enzymotec Ltd. is a biotechnology company based in Migdal Haemeq, Israel, specializing in the development, manufacture, and marketing of bio-functional lipid ingredients and medical foods. The company operates primarily in North America, the European Union, Australia, New Zealand, Asia, and Israel. Enzymotec's Nutrition segment focuses on lipid-based nutritional ingredients, including phospholipids that mimic human breast milk fat for infant formulas, soy-derived phosphatidylserine products aimed at enhancing cognitive performance, and krill oil rich in omega-3 fatty acids. Its offerings also extend to supplements designed for memory improvement in various age groups. The VAYA Pharma segment develops lipid-based medical foods targeting cardiovascular and neurological health, including products for managing attention deficit-hyperactivity disorder and early memory impairment. Founded in 1998, Enzymotec has positioned itself as a provider of advanced nutritional and medical solutions that address health needs across the human life cycle.
Spot something off? Help us improve by flagging any incorrect or outdated information. Just email us at support@teaserclub.com. Your feedback is most welcome.